Key result
Biofilms promote systemic cardiovascular, metabolic, and neurological diseases by driving chronic inflammation and immune evasion.
Answers are grounded in this paper and cite their sources.
This review highlights the underestimated role of bacterial biofilms in the pathogenesis of systemic chronic diseases, including cardiovascular and metabolic conditions, suggesting novel therapeutic avenues.
Biofilms, intricate microbial communities enclosed in a protective extracellular matrix, are conventionally linked to localized illnesses. Emerging data indicates that biofilms significantly contribute to systemic disorders beyond traditional infections. Bacterial biofilms may induce neuroinflammation and impair the blood-brain barrier in neurodegenerative illnesses including Alzheimer's and Parkinson's. In cardiovascular illnesses, biofilms from oral and gut microbes play a role in atherosclerosis, endocarditis, and hypertension. In metabolic illnesses, biofilms affect insulin resistance and metabolic endotoxemia, worsening conditions such as obesity and type 2 diabetes. Moreover, biofilms are associated with cancer progression, especially in colorectal and gastric malignancies, as they provide a tumor-promoting milieu via chronic inflammation and the generation of bacterial metabolites. Biofilms advance disease development by increasing chronic inflammation, evading immunological responses, and allowing microbial translocation, aspects that have been previously underestimated. Identifying biofilms as significant contributors to systemic disease presents novel avenues for innovative therapies and enhanced patient outcomes across various chronic illnesses. Thus, this review examines the increasing influence of biofilms on chronic inflammatory diseases, neurological disorders, cardiovascular diseases, metabolic syndromes, and cancer.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) conducted a review in Neurological, cardiovascular, and metabolic diseases. Biofilms was evaluated. Biofilms significantly contribute to systemic disorders, including neurological, cardiovascular, and metabolic diseases, by increasing chronic inflammation and evading immunological responses.
Synapse has enriched 10 related papers. Consider them for comparative context: